You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Litigation Details for Bayer Intellectual Property GMBH v. Taro Pharmaceutical Industries Ltd. (D. Del. 2017)


✉ Email this page to a colleague

« Back to Dashboard


Bayer Intellectual Property GMBH v. Taro Pharmaceutical Industries Ltd. (D. Del. 2017)

Docket ⤷  Try a Trial Date Filed 2017-04-21
Court District Court, D. Delaware Date Terminated 2020-09-02
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties AUROBINDO PHARMA USA INC.
Patents 6,168,016; 7,157,456; 7,585,860; 7,592,339; 9,415,053; 9,539,218
Attorneys Lynne Terrebonne
Firms Phillips, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Bayer Intellectual Property GMBH v. Taro Pharmaceutical Industries Ltd.
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .
Biologic Drugs cited in Bayer Intellectual Property GMBH v. Taro Pharmaceutical Industries Ltd.
The biologic drug covered by the patents cited in this case is ⤷  Try a Trial .

Details for Bayer Intellectual Property GMBH v. Taro Pharmaceutical Industries Ltd. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2018-07-12 102 Stipulation-General (See Motion List for Stipulation to Extend Time) Proposed] Order Regarding Infringement of U.S. Patent No. 9,539,218 by Sigmapharm Laboratories, LLC. (Myer, … 2 September 2020 1:17-cv-00462 830 Patent None District Court, D. Delaware External link to document
2018-07-19 108 Stipulation-General (See Motion List for Stipulation to Extend Time) Proposed] Order Regarding Infringement of U.S. Patent No. 9,539,218 by InvaGen Pharmaceuticals, Inc.. (Myer,… 2 September 2020 1:17-cv-00462 830 Patent None District Court, D. Delaware External link to document
2018-07-24 109 Order 1-4 of U.S. Patent No. 9,539,218 ("the Asserted Claims of the '218 Patent"), provided…and Order Regarding Infringement of U.S. Patent No. 9,539,218. Signed by Judge Richard G. Andrews on 7… INFRINGEMENT OF U.S. PATENT NO. 9,539,218 Plaintiff Bayer Intellectual Property…infringement of the Asserted Claims of the '218 Patent, provided the claim at issue is not proven invalid…infringement of the Asserted Claims of the '218 patent. 4. Nothing in this stipulation shall External link to document
2019-03-22 150 Pretrial Order assert all four claims of U.S. Patent No. 9,539,218 (“the ’218 patent”). 2. By letter dated…the ’218 patent. Plaintiffs timely filed complaints alleging infringement of the ’218 patent against …Legible, accurate copies of United States patents and foreign patents, as well as their corresponding prosecutions… 1. This is a consolidated action for patent infringement under the Hatch-Waxman Act. Plaintiffs…rivaroxaban tablets prior to the expiration of the ’218 patent. Mylan’s letter also notified BIP and Janssen External link to document
2019-03-29 156 166:7 167:1 167:16 168:1 168:6 168:16 168:23 174:6 175:6 177:10 …reference to a U.S. patent or U.S. patent application publication, which patent or patent application publication… I. The Patent-In-Suit 1. U.S. Patent No. 9,539,218 (“the ’218 patent”), entitled … on U.S. Patent No. 7,157,456 (“the ’456 patent”), which is not prior art. The ’456 patent issued from… on U.S. Patent No. 7,592,339 (“the ’339 patent”), which is not prior art. The ’339 patent issued from External link to document
2019-04-02 157 Opinion tablet” in claims 1–4 of U.S. Patent No. 9,539,218 (“the ’218 patent”). Before the court are Joint Pretrial… to the expiration of the ’218 patent.1 Claim 1 of the ’218 patent recites: 1. A method of treating…012897, which is referenced in the ’218 patent. The ’218 patent specification states that “[p]reparation… reference.” ’218 patent, col. 8, ll. 28–30. Mylan points out that the patent cites “the wrong number…well-settled that, in a patent infringement suit, a district court can construe a patent to correct an obvious External link to document
2019-11-04 191 Consent Judgment - Proposed infringement of United States Patent No. 9,539,218 (“the ’218 patent”); WHEREAS Janssen currently…the term of the ’218 patent, including any patent term extensions and/or patent term adjustments and …prior to the expiration of the ’218 patent was a technical act of patent infringement with respect to the…prior to the expiration of the ’218 patent was a technical act of patent infringement with respect to the…’218 patent under 35 U.S.C. §271(e)(2)(A). 3. The asserted claims of the ’218 patent are External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.